Company registration number 09476881 (England and Wales)
PLB Healthcare Ltd
Unaudited Financial Statements
For the year ended 31 March 2026
PLB Healthcare Ltd
Contents
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
PLB Healthcare Ltd
Balance Sheet
As at 31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
1,510
1,632
Investments
4
3,310
1,052
4,820
2,684
Current assets
Debtors
6
92,336
121,283
Cash at bank and in hand
46,214
73,601
138,550
194,884
Creditors: amounts falling due within one year
7
(46,432)
(53,235)
Net current assets
92,118
141,649
Total assets less current liabilities
96,938
144,333
Creditors: amounts falling due after more than one year
8
-
0
(3,008)
Net assets
96,938
141,325
Capital and reserves
Called up share capital
200
200
Profit and loss reserves
96,738
141,125
Total equity
96,938
141,325
PLB Healthcare Ltd
Balance Sheet (continued)
As at 31 March 2026
- 2 -

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 1 August 2026 and are signed on its behalf by:
Dr P Boyd
Director
Company registration number 09476881 (England and Wales)
PLB Healthcare Ltd
Notes to the financial statements
For the year ended 31 March 2026
- 3 -
1
Accounting policies
Company information

PLB Healthcare Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Chester House Lloyd Drive, Cheshire Oaks Business Park, Ellesmere Port, Cheshire, England, CH65 9HQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. The activity of the company is exempt from VAT.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

PLB Healthcare Ltd
Notes to the financial statements (continued)
For the year ended 31 March 2026
1
Accounting policies
(Continued)
- 4 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PLB Healthcare Ltd
Notes to the financial statements (continued)
For the year ended 31 March 2026
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

PLB Healthcare Ltd
Notes to the financial statements (continued)
For the year ended 31 March 2026
1
Accounting policies
(Continued)
- 6 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
PLB Healthcare Ltd
Notes to the financial statements (continued)
For the year ended 31 March 2026
- 7 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2025
2,495
Additions
381
At 31 March 2026
2,876
Depreciation and impairment
At 1 April 2025
863
Depreciation charged in the year
503
At 31 March 2026
1,366
Carrying amount
At 31 March 2026
1,510
At 31 March 2025
1,632
4
Fixed asset investments
2026
2025
£
£
Other investments other than loans
3,310
1,052
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2025
1,052
Additions
1,794
Valuation changes
464
At 31 March 2026
3,310
Carrying amount
At 31 March 2026
3,310
At 31 March 2025
1,052
5
Financial instruments
2026
2025
£
£
Carrying amount of financial assets include:
Instruments measured at fair value through profit or loss
3,310
1,052
PLB Healthcare Ltd
Notes to the financial statements (continued)
For the year ended 31 March 2026
- 8 -
6
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
18,175
21,283
Other debtors
4,161
-
0
22,336
21,283
2026
2025
Amounts falling due after more than one year:
£
£
Other debtors
70,000
100,000
Total debtors
92,336
121,283
7
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans
3,172
6,389
Corporation tax
40,150
44,108
Other creditors
3,110
2,738
46,432
53,235
8
Creditors: amounts falling due after more than one year
2026
2025
£
£
Bank loans and overdrafts
-
0
3,008
9
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

Orthodontic Services
2026
2025
£
£
Other related parties
196,701
196,494
PLB Healthcare Ltd
Notes to the financial statements (continued)
For the year ended 31 March 2026
9
Related party transactions
(Continued)
- 9 -

The following amounts were outstanding at the reporting end date:

2026
2025
Amounts due from related parties
£
£
Other related parties
70,000
100,000
10
Directors' transactions
Advances
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
-
818
312
1,130
818
312
1,130
11
Parent company

The ultimate controlling party was Dr P Boyd.

2026-03-31 2025-04-01 false false false 01 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr P Boyd Dr L J Coulter 09476881 2025-04-01 2026-03-31 09476881 2026-03-31 09476881 2025-03-31 09476881 core:OtherPropertyPlantEquipment 2026-03-31 09476881 core:OtherPropertyPlantEquipment 2025-03-31 09476881 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 09476881 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09476881 core:Non-currentFinancialInstruments core:AfterOneYear 2026-03-31 09476881 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 09476881 core:ShareCapital 2026-03-31 09476881 core:ShareCapital 2025-03-31 09476881 core:RetainedEarningsAccumulatedLosses 2026-03-31 09476881 core:RetainedEarningsAccumulatedLosses 2025-03-31 09476881 bus:Director1 2025-04-01 2026-03-31 09476881 core:ComputerEquipment 2025-04-01 2026-03-31 09476881 2024-04-01 2025-03-31 09476881 core:OtherPropertyPlantEquipment 2025-03-31 09476881 core:OtherPropertyPlantEquipment 2025-04-01 2026-03-31 09476881 core:CurrentFinancialInstruments 2026-03-31 09476881 core:CurrentFinancialInstruments 2025-03-31 09476881 core:Non-currentFinancialInstruments 1 2026-03-31 09476881 core:Non-currentFinancialInstruments 1 2025-03-31 09476881 core:Non-currentFinancialInstruments 2026-03-31 09476881 core:Non-currentFinancialInstruments 2025-03-31 09476881 2025-03-31 09476881 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09476881 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 09476881 bus:FRS102 2025-04-01 2026-03-31 09476881 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 09476881 bus:Director2 2025-04-01 2026-03-31 09476881 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP